Citius Pharmaceuticals Inc vs Symbotic Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.64M), while Symbotic Inc trades at $44.01 (market cap $5.55B). The key difference: Symbotic Inc is far larger — about 379.1× Citius Pharmaceuticals Inc's market cap, and Symbotic Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | SYM | |
|---|---|---|
Market Cap | $14.64M | $5.55B |
Sector | Health | Technology |
52-Week High | $1.82 | $87.30 |
52-Week Low | $0.53 | $38.57 |
Enterprise Value | $10.86M | $3.54B |
Trailing returns across standard periods
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →